Effect of saroglitazar 2 mg and 4 mg on glycemic control, lipid profile and cardiovascular disease r...
Effect of saroglitazar 2 mg and 4 mg on glycemic control, lipid profile and cardiovascular disease risk in patients with type 2 diabetes mellitus: a 56-week, randomized, double blind, phase 3 study (PRESS XII study)
About this item
Full title
Author / Creator
Krishnappa, Manjunath , Patil, Kishor , Parmar, Krupi , Trivedi, Purav , Mody, Nirali , Shah, Chintan , Faldu, Khushboo , Maroo, Sanjay , Desai, Piyush , Fatania, Kamlesh , Murthy, Satyanarayan , Balamurugan, R. , Agarwal, Manish , Singh, K. P. , Kalra, G. S. , Khandelwal, Vipul , Singwala, Ashish , Thacker, Hemant , Tulle, Rahul , Rao, Harish , Kumbla, Mukund , Singh, Parminder , Khatri, Ashok , Agrawal, Sumit , Sarkar, R. N. , Agarwal, Dinesh , Bhatia, Girish , Agarwal, R. P. , Kumar, Surender , Vamsi Krishna, P. R. , Ajmani, Ajay Kumar , Asalkar, Amit , Basu, Indraneel , Chatterjee, Sudip , Pavithran, Vinod Kumar , Das, Rupam , Dharmadhikari, Aniruddha , Vardhan, Vikram , Madusudhan Babu, M. , Sengupta, Nilanjan , Abkari, Srirang , Harikrishna, R. , Chovatia, Rashmi , Parmar, Deven , for the PRESS XII study group and PRESS XII study group
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
The potential for PPAR agonists to positively affect risk of cardiovascular disease in patients with type 2 diabetes (T2DM) is of persistent attention. The PRESS XII study primarily aimed to evaluate the efficacy and safety of saroglitazar (2 mg and 4 mg) as compared to pioglitazone 30 mg on glycemic control in patients with type 2 diabetes mellitu...
Alternative Titles
Full title
Effect of saroglitazar 2 mg and 4 mg on glycemic control, lipid profile and cardiovascular disease risk in patients with type 2 diabetes mellitus: a 56-week, randomized, double blind, phase 3 study (PRESS XII study)
Authors, Artists and Contributors
Author / Creator
Patil, Kishor
Parmar, Krupi
Trivedi, Purav
Mody, Nirali
Shah, Chintan
Faldu, Khushboo
Maroo, Sanjay
Desai, Piyush
Fatania, Kamlesh
Murthy, Satyanarayan
Balamurugan, R.
Agarwal, Manish
Singh, K. P.
Kalra, G. S.
Khandelwal, Vipul
Singwala, Ashish
Thacker, Hemant
Tulle, Rahul
Rao, Harish
Kumbla, Mukund
Singh, Parminder
Khatri, Ashok
Agrawal, Sumit
Sarkar, R. N.
Agarwal, Dinesh
Bhatia, Girish
Agarwal, R. P.
Kumar, Surender
Vamsi Krishna, P. R.
Ajmani, Ajay Kumar
Asalkar, Amit
Basu, Indraneel
Chatterjee, Sudip
Pavithran, Vinod Kumar
Das, Rupam
Dharmadhikari, Aniruddha
Vardhan, Vikram
Madusudhan Babu, M.
Sengupta, Nilanjan
Abkari, Srirang
Harikrishna, R.
Chovatia, Rashmi
Parmar, Deven
for the PRESS XII study group
PRESS XII study group
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_bc36f5900d644e158456c59a7de79a28
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_bc36f5900d644e158456c59a7de79a28
Other Identifiers
ISSN
1475-2840
E-ISSN
1475-2840
DOI
10.1186/s12933-020-01073-w
